Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ductal, Breast × pertuzumab × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 58 Neoplasms 8 HER2-positive Breast Cancer 8 Neoplasm Metastasis 3 Endometrial Neoplasms 3 Colonic Neoplasms 3 Anatomic Stage I Breast Cancer AJCC v8 3 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Salivary Gland Neoplasms 2 Prostatic Neoplasms 2 Pathologic Complete Response 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Inflammatory Breast Neoplasms 2 Hematologic Neoplasms 2 HER2-positive Early Breast Cancer 2 Brain Neoplasms 2 Biliary Tract Neoplasms 2 Anatomic Stage II Breast Cancer AJCC v8 2 Urinary Bladder Neoplasms 1 Solid Tumors 1 Solid Cancer 1 Skin Neoplasms 1 Resectable HER2-positive Breast Cancer 1 Recurrence 1 Rectal Neoplasms 1 Patient Preference 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1

Interventions

Radiotherapy 2 talimogene laherparepvec 1 Reverse Transcriptase Polymerase Chain Reaction 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Image-Guided 1 Radiation 1 Paclitaxel 1 Mastectomy, Segmental 1 Mastectomy 1 Mass Spectrometry 1 Immunohistochemistry 1 Gene Expression Profiling 1 Fulvestrant 1 Fluorescent Antibody Technique 1 Counseling 1 Chromatography, Liquid 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡